People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Digene hires new chief: Daryl Faulkner succeeds Evan Jones in the top spot at papillomavirus test manufacturer Digene, effective Dec. 11. Faulkner will be tasked with expanding the firm's product portfolio beyond its flagship HPV test through R&D, in-licensing and acquisitions. As VP-general manager at Invitrogen, Faulkner helped grow the business to more than $1 bil. in annual revenues. Digene founder Jones, who in June announced plans to retire after 16 years as CEO, will continue to serve on the board of directors (1"The Gray Sheet" June 12, 2006, In Brief)...
You may also be interested in...
Digene Will Achieve Strategic Goals Faster Through Qiagen Merger, CEO Says
Human papillomavirus test maker Digene will expand its international presence and gain critical mass to help counter looming competition in the lucrative HPV test market by merging with Dutch molecular diagnostics firm Qiagen
Digene Will Achieve Strategic Goals Faster Through Qiagen Merger, CEO Says
Human papillomavirus test maker Digene will expand its international presence and gain critical mass to help counter looming competition in the lucrative HPV test market by merging with Dutch molecular diagnostics firm Qiagen
Digene CEO departing
Firm announces upcoming retirement of co-founder and CEO Evan Jones June 8. Having been at the helm for 16 years - from the company's inception through commercialization of its hc2 High-Risk HPV DNA Test, which has captured about 17% of the U.S. cervical cancer screening market - Jones will continue to serve as a board member...